Investing in the Intersection of Artificial Intelligence and Healthcare

Our Investment Criteria


Seed-stage*, U.S.-based** companies that integrate AI as a core component of their technology in one of the following four verticals:

Biotech/Pharma Tools


We do NOT invest in drug development—only in the tools and technologies that enable it

Medical Devices


Must have a clear path to accelerated regulatory approval

Diagnostics


Prioritizing rapid, scalable, and cost-effective solutions

Healthcare SaaS


Data-driven platforms with clear market adoption

*We loosely define seed-stage as the first dilutive round of capital from institutional investors.


**We define U.S.-based as having an operational C-Corporation already established, with team members physically based in America. We do NOT fund companies that are ‘planning’ to establish in the U.S.—you must already be operational here.


Investing in the automation of healthcare

 testimonial header

Special features

Contact us

Follow

Share by: